Heart disease is the leading cause of death in the United States, and doctors suggest you might benefit from monitoring your ...

The US Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in ...

Representatives with Extivita Healthcare—a company that specializes in HBOT clinics—spoke to local leaders about the value the therapy could bring to the community on Thursday.

Pharmapack Europe has announced the winners of its newly reformatted Pharmapack Awards, recognizing excellence in six key ...

In today's fast-paced world, many individuals struggle with respiratory issues, whether due to chronic conditions like asthma ...

Inogen, Inc. INGN is well-poised for growth in the coming quarters, courtesy of high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid fourth-quarter 2024 ...

Portable Oxygen Concentrator Market. According to a revised research study by Future Market Insights, the global portable ...

The biggest challenge in training the next generation of respiratory therapists is getting them to engage in "critical ...

(CBS DETROIT) - Investigators continue to search for answers after a 5-year-old Royal Oak boy was killed when a hyperbaric ...

A dad-of-two left homeless after a fire swept through his Dublin house last week has appealed for funds to house his daughter ...

As reported in Biophotonics Discovery, the team developed a novel microscopy technique that uses a standard fluorescence microscope in combination with imaging software. This method allows scientists ...

The global hyperbaric oxygen therapy (HBOT) devices market, valued at USD 3.47 billion in 2023, is poised for significant growth, reaching USD 6.86 billion by 2033 at a CAGR of 7.0%. This surge is ...